Translocation of an intracellular antigen to the surface of medullary breast cancer cells early in apoptosis allows for an antigen-driven antibody response elicited by tumor-infiltrating B cells

Journal of Immunology

Volumn 169, Issue 5, 2002, Pages 2701-2711

  Hansen, Margit H ^a   Nielsen, Heidi V ^a   Ditzel, Henrik J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2;

ANTIBODY RESPONSE; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BREAST CANCER; CELL SURFACE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; MEDULLARY CARCINOMA; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SEQUENCE ANALYSIS; SURFACE PLASMON RESONANCE; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0036721786     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.5.2701     Document Type: Article

References (72)

1. Medullary carcinoma of the breast: A clinicopathologic study with appraisal of current diagnostic criteria
2. Prognostic comparison of three classifications for medullary carcinomas of the breast
3. Medullary carcinoma of the breast
4. Medullary breast carcinoma: A revaluation of 95 cases of breast cancer with inflammatory stroma
5. Typical medullary carcinoma of the breast: A clinical and pathological analysis of 52 cases
6. Medullary carcinoma of the breast, proposal for a new simplified histopathological definition
7. Pathological prognostic factors in breast cancer. II. Histological type: Relationship with survival in a large study with long-term follow-up
8. MIB-1 expression in breast carcinomas with medullary features: An immunohistological study including correlations with p53 and bcl-2
9. Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas
10. p53 mutations and histological type of invasive breast carcinoma
11. p53 mutation as a genetic trait of typical medullary breast carcinoma
12. Mutations at BRCAI: The medullary breast carcinoma revisited
13. WNT pathway and mammary carcinogenesis: Loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type
14. Class distribution of immunoglobulin-containing plasma cells in the stroma of medullary carcinoma of breast
15. Medullary carcinoma of the breast: Identification of lymphocyte subpopulations and their significance
16. Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast
17. Immunohistochemical study of T and B lymphocytes in human breast carcinomas with inflammatory stroma
18. The tumor filtrating B cell response in medullary breast cancer is oligoclonal and directed against an intracellular antigen exposed on the surface of apoptotic cancer cells
19. Apoptosis and cell proliferation in medullary carcinoma of the breast: A comparative study between medullary and non-medullary carcinoma using the TUNEL method and immunohistochemistry
20. Apoptosis, proliferation, and Fas (APO-1, CD95)/Fas ligand expression in medullary carcinoma of the breast
21. Evidence for an antigen-driven humoral immune response in medullary ductal breast cancer
22. Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: Recovery from a long-term-nonprogressor SIV-infected macaque
23. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals
24. Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure
25. Cloning and expression of a novel human antibody-antigen pair associated with Felty's syndrome
26. Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system
27. Evaluation of prodecures for the fixation and processing of human tissue for immunohistochemical analysis of human monoclonal antibodies
28. Immunoglobulin synthesis in the "resting" breast
29. Human antibodies from combinatorial libraries
30. Somatic mutations in variable regions of human IgG anti-double-stranded DNA autoantibody suggest a role for antigen in induction of systemic lupus erythematosus
31. +) cells make somatically hypermutated high affinity IgM rhematoid factors
32. HIII segments and somatic hypermutation
33. VH and VL segment structure of anti-insulin IgG autoantibodies in patients with insulin-dependent diabetes mellitus: Evidence for somatic selection
34. Patterns of human tumor infiltrating lymphocytes in 120 human cancers
35. Antigenic phenotype of the lymphocytic component of medullary carcinoma of the breast
36. Medullary carcinoma of the breast, prognostic importance of characteristic histopathological features evaluated in a multivariate Cox analysis
37. Medullary carcinoma of the breast: Prevalence and prognostic importance of classical risk factors in breast cancer
38. Medullary carcinoma is associated with expression of intracellular adhesion molecule-1: Implication to its morphology and its clinical behavior
39. 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: Histopathologically similar but biologically distinct entities
40. High endothelial venule and immunocomponent cells in typical medullary carcinoma of the breast
41. p53 antibodies in the sera of patients with various types of cancer: A review
42. Cancer tumor antigens
43. The I.M.A.G.E. consortium: An integrated molecular analysis of genomes and their expression
44. Antinuclear antibodies as potential markers of lung cancer
45. Autoantibodies in three populations of Burkitt's lymphoma patients
46. Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries
47. Human autoantibody recognition of DNA
48. Selection of recombinant anti-HuD Fab fragments from a phage display antibody library of a lung cancer patient with paraneoplastic encephalomyelitis
49. 12
50. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis
51. Antiactin antibodies in sera from patients with autoimmune liver diseases and patients with carcinomas by ELISA
52. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl
53. Annexin V-affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure
54. Cleavage of actin by interleukin 1β-converting enzyme to reverse DNase 1 inhibition
55. Apoptosis: The molecular basis of cell death
56. Relationship between actin microfilaments and plasma membrane changes during apoptosis of neoplastic cell lines in different culture conditions
57. + T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer
58. Histological type and syncytial growth pattern affect E-cadherin expression in a multifactorial analysis of a combined panel of sporadic and BRCAI-associated breast cancers
59. The structural and functional analysis of cadherin calcium-dependent cell adhesion molecules
60. Cadherin cell adhesion receptors as morphogenetic regulator
61. BRCAI and medullary breast cancer
62. Mutations at BRCAI: The medullary breast carcinoma revisited
63. Cleavage by granzyme B is strongly predictive of autoantigen status: Implications for initiation of autoimmunity
64. Activation of the apoptofic protease CPP32 by cytotoxic T-cell-derived granzyme B
65. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: Implications for coagulation events and antigenic spread in systemic lupus erythematosus
66. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes
67. Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming
68. Autoantibodies in the serum of patients with gastric cancer: Their prognostic importance
69. (Auto)antibodies in human breast cancer sera against antigens associated with breast cancer cells, detected by immunoblotting
70. Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: A population-based epidemiological study
71. Humoral response to p53 in human colorectal tumors: A prospective study of 1,209 patients
72. P53 autoantibodies in 1006 patients followed up for breast cancer